home / stock / sppi / sppi news


SPPI News and Press, Spectrum Pharmaceuticals Inc. From 11/03/21

Stock Information

Company Name: Spectrum Pharmaceuticals Inc.
Stock Symbol: SPPI
Market: NASDAQ
Website: sppirx.com

Menu

SPPI SPPI Quote SPPI Short SPPI News SPPI Articles SPPI Message Board
Get SPPI Alerts

News, Short Squeeze, Breakout and More Instantly...

SPPI - Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021 at 4...

SPPI - MONDAY DEADLINE: Spectrum Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Case - SPPI

San Diego, California--(Newsfile Corp. - October 26, 2021) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) securities between December 27, 2018 and August 5, 2021, inclusive (the "Class Period"...

SPPI - Spectrum Pharmaceuticals Announces Presentation of Poziotinib in Combination with KRASG12C Inhibitors at the 2021 AACR-NCI-EORTC Conference

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of preclinical data demonstrating the synergistic impact of poziotinib when combined with KRAS inhibitors in KRAS G12C mutant spe...

SPPI - Cohen Milstein Investigates Spectrum Pharmaceuticals, Inc. on Shareholders' Behalf

WASHINGTON, DC / ACCESSWIRE / October 4, 2021 / Cohen Milstein Sellers & Toll PLLC is investigating Spectrum Pharmaceuticals, Inc. (NYSE:SPPI) ("Spectrum Pharmaceuticals" or the "Company") following the filing of class action lawsuits alleging violations of federal securities law. I...

SPPI - FIXX, DTIL, EAR and SYBX among after hours movers

Gainers: FIXX +9.8%. DTIL +7.6%. REGI +5.3%. SPPI +5.2%. RANI +4.7%. Losers: EAR -51.2%. SYBX -8.9%. GRIN -6.4%. QRVO -6.4%. FA -5.0%. For further details see: FIXX, DTIL, EAR and SYBX among after hours movers

SPPI - Spectrum Pharmaceuticals to Participate in 2021 Cantor Virtual Global Healthcare Conference

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the 2021 Cantor Virtual Global Healthcare Conference. A fireside chat is scheduled for Wednesday, September 29, 20...

SPPI - Hot Stocks: Chinese stocks fall; LI lowers deliveries guidance; MRTX, SPPI data

The major U.S. equity averages saw significant weakness in Monday's pre-market trading, led lower by a drop in Chinese stocks. JD.com, Inc. (NASDAQ:JD), Alibaba (NYSE:BABA) and Baidu (NASDAQ:BIDU) were among the high-profile names losing ground. Other stocks fell on company-specific headlines...

SPPI - SDC, EDSA and APRE among pre market gainers

ZIVO Bioscience (NASDAQ:ZIVO) +175%. Verastem (NASDAQ:VSTM) +22% Oncology's VS-6766 + defactinib combo shows promising action in ovarian cancer study Edesa Biotech (NASDAQ:EDSA) +33% announces positive phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients ER...

SPPI - Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts

Are Biotech Penny Stocks On Your Watch List This Week? Penny stocks are well known for their volatility swings. Whether we’re talking about stocks with insider trading, meme stocks, or penny stocks with high analyst ratings, there are myriad catalysts to seek out. However, sp...

SPPI - Spectrum Pharmaceuticals Presents Late Breaker Oral Presentation of Poziotinib Data in First-Line NSCLC Patients with HER2 Exon 20 Insertion Mutations at ESMO Congress 2021

Early data from Cohort 4 of the ongoing ZENITH20 clinical trial shows ORR of 44% in 48 first-line patients treated with 16mg of poziotinib once daily Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology thera...

Previous 10 Next 10